Omnicell, Inc. Price to Sales Ratio 2010-2024 | OMCL
Historical PS ratio values for Omnicell, Inc. (OMCL) over the last 10 years. The current P/S ratio for Omnicell, Inc. as of February 21, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Omnicell, Inc. P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2025-02-21 |
39.72 |
|
1.65 |
| 2024-12-31 |
44.52 |
$24.03 |
1.85 |
| 2024-09-30 |
43.60 |
$23.20 |
1.88 |
| 2024-06-30 |
27.07 |
$23.67 |
1.14 |
| 2024-03-31 |
29.23 |
$24.23 |
1.21 |
| 2023-12-31 |
37.63 |
$25.33 |
1.49 |
| 2023-09-30 |
45.04 |
$26.09 |
1.73 |
| 2023-06-30 |
73.67 |
$27.13 |
2.72 |
| 2023-03-31 |
58.67 |
$27.72 |
2.12 |
| 2022-12-31 |
50.42 |
$27.90 |
1.81 |
| 2022-09-30 |
87.03 |
$27.90 |
3.12 |
| 2022-06-30 |
113.75 |
$26.44 |
4.30 |
| 2022-03-31 |
129.49 |
$25.06 |
5.17 |
| 2021-12-31 |
180.44 |
$23.84 |
7.57 |
| 2021-09-30 |
148.43 |
$23.05 |
6.44 |
| 2021-06-30 |
151.45 |
$21.81 |
6.94 |
| 2021-03-31 |
129.87 |
$20.70 |
6.27 |
| 2020-12-31 |
120.02 |
$20.53 |
5.85 |
| 2020-09-30 |
74.66 |
$20.62 |
3.62 |
| 2020-06-30 |
70.62 |
$21.04 |
3.36 |
| 2020-03-31 |
65.58 |
$21.42 |
3.06 |
| 2019-12-31 |
81.72 |
$20.95 |
3.90 |
| 2019-09-30 |
72.27 |
$20.39 |
3.54 |
| 2019-06-30 |
86.03 |
$20.07 |
4.29 |
| 2019-03-31 |
80.84 |
$19.73 |
4.10 |
| 2018-12-31 |
61.24 |
$19.54 |
3.13 |
| 2018-09-30 |
71.90 |
$19.39 |
3.71 |
| 2018-06-30 |
52.45 |
$19.18 |
2.73 |
| 2018-03-31 |
43.40 |
$19.18 |
2.26 |
| 2017-12-31 |
48.50 |
$18.62 |
2.61 |
| 2017-09-30 |
51.05 |
$18.30 |
2.79 |
| 2017-06-30 |
43.10 |
$18.27 |
2.36 |
| 2017-03-31 |
40.65 |
$18.36 |
2.21 |
| 2016-12-31 |
33.90 |
$19.11 |
1.77 |
| 2016-09-30 |
38.30 |
$17.90 |
2.14 |
| 2016-06-30 |
34.23 |
$16.56 |
2.07 |
| 2016-03-31 |
27.87 |
$14.80 |
1.88 |
| 2015-12-31 |
31.08 |
$13.16 |
2.36 |
| 2015-09-30 |
31.10 |
$12.93 |
2.40 |
| 2015-06-30 |
37.71 |
$12.57 |
3.00 |
| 2015-03-31 |
35.10 |
$12.39 |
2.83 |
| 2014-12-31 |
33.12 |
$12.05 |
2.75 |
| 2014-09-30 |
27.33 |
$11.68 |
2.34 |
| 2014-06-30 |
28.71 |
$11.23 |
2.56 |
| 2014-03-31 |
28.62 |
$11.01 |
2.60 |
| 2013-12-31 |
25.53 |
$10.70 |
2.38 |
| 2013-09-30 |
23.68 |
$10.38 |
2.28 |
| 2013-06-30 |
20.55 |
$10.26 |
2.00 |
| 2013-03-31 |
18.88 |
$9.81 |
1.92 |
| 2012-12-31 |
14.87 |
$9.18 |
1.62 |
| 2012-09-30 |
13.90 |
$8.39 |
1.66 |
| 2012-06-30 |
14.64 |
$7.79 |
1.88 |
| 2012-03-31 |
15.21 |
$7.39 |
2.06 |
| 2011-12-31 |
16.52 |
$7.20 |
2.29 |
| 2011-09-30 |
13.78 |
$7.06 |
1.95 |
| 2011-06-30 |
15.59 |
$6.86 |
2.27 |
| 2011-03-31 |
15.24 |
$6.70 |
2.28 |
| 2010-12-31 |
14.45 |
$6.66 |
2.17 |
| 2010-09-30 |
13.08 |
$6.65 |
1.97 |
| 2010-06-30 |
11.69 |
$6.64 |
1.76 |
| 2010-03-31 |
14.03 |
$6.65 |
2.11 |
| 2009-12-31 |
11.69 |
$6.68 |
1.75 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MEDICAL INFO SYS |
$1.840B |
$1.112B |
|
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
| Veeva Systems Inc. (VEEV) |
US |
$36.657B |
54.02 |
| Hims & Hers Health, Inc. (HIMS) |
US |
$10.767B |
273.78 |
| Tempus AI, Inc. (TEM) |
US |
$10.720B |
0.00 |
| Inspire Medical Systems, Inc. (INSP) |
US |
$5.261B |
102.50 |
| iRhythm Technologies (IRTC) |
US |
$3.752B |
0.00 |
| Privia Health Group, Inc. (PRVA) |
US |
$2.942B |
245.20 |
| Enovis Corporation (ENOV) |
US |
$2.428B |
16.18 |
| Clover Health Investments, Corp. (CLOV) |
US |
$2.205B |
0.00 |
| Azenta, Inc. (AZTA) |
US |
$2.045B |
95.21 |
| Schrodinger, Inc. (SDGR) |
US |
$1.650B |
0.00 |
| Phreesia, Inc. (PHR) |
US |
$1.640B |
0.00 |
| 10x Genomics (TXG) |
US |
$1.333B |
0.00 |
| Butterfly Network, Inc. (BFLY) |
US |
$0.916B |
0.00 |
| Talkspace, Inc. (TALK) |
US |
$0.508B |
300.50 |
| Fulgent Genetics, Inc. (FLGT) |
US |
$0.503B |
0.00 |
| Standard BioTools Inc. (LAB) |
US |
$0.484B |
0.00 |
| TruBridge, Inc. (TBRG) |
US |
$0.422B |
122.87 |
| Pulmonx Corporation (LUNG) |
US |
$0.354B |
0.00 |
| Nyxoah SA (NYXH) |
BE |
$0.352B |
0.00 |
| Health Catalyst, Inc. (HCAT) |
US |
$0.318B |
0.00 |
| SOPHiA GENETICS SA (SOPH) |
CH |
$0.266B |
0.00 |
| American Well Corporation (AMWL) |
US |
$0.183B |
0.00 |
| EUDA Health Holdings Limited (EUDA) |
SG |
$0.098B |
0.00 |
| MDxHealth SA (MDXH) |
BE |
$0.088B |
0.00 |
| P3 Health Partners Inc. (PIII) |
US |
$0.075B |
0.00 |
| 111, Inc. Sponsored ADR (YI) |
CN |
$0.072B |
0.00 |
| CareCloud, Inc. (CCLD) |
US |
$0.058B |
0.00 |
| HeartBeam, Inc. (BEAT) |
US |
$0.055B |
0.00 |
| Outset Medical, Inc. (OM) |
US |
$0.047B |
0.00 |
| Zepp Health Corporation Sponsored ADR (ZEPP) |
CN |
$0.045B |
0.00 |
| SHL Telemedicine Ltd. Unsponsored ADR (SHLT) |
IL |
$0.038B |
0.00 |
| Zhongchao Inc. (ZCMD) |
CN |
$0.035B |
0.00 |
| Movano Inc. (MOVE) |
US |
$0.033B |
0.00 |
| Bullfrog AI Holdings Inc. (BFRG) |
US |
$0.025B |
0.00 |
| MSP Recovery, Inc. (MSPR) |
US |
$0.016B |
0.00 |
| Streamline Health Solutions, Inc. (STRM) |
US |
$0.015B |
0.00 |
| Precipio, Inc. (PRPO) |
US |
$0.015B |
0.00 |
| ImmunoPrecise Antibodies Ltd. (IPA) |
CA |
$0.012B |
0.00 |
| Mobile-health Network Solutions (MNDR) |
SG |
$0.012B |
0.00 |
| Strata Skin Sciences, Inc. (SSKN) |
US |
$0.011B |
0.00 |
| Predictive Oncology Inc. (POAI) |
US |
$0.010B |
0.00 |
| Syra Health Corp. (SYRA) |
US |
$0.005B |
0.00 |
| Tivic Health Systems, Inc. (TIVC) |
US |
$0.004B |
0.00 |
| HeartSciences Inc. (HSCS) |
US |
$0.004B |
0.00 |
| Healthcare Triangle, Inc. (HCTI) |
US |
$0.003B |
0.00 |
| Future Health ESG Corp. (FHLT) |
US |
$0.000B |
0.00 |
